Renalytix plc (RENX) Issues Shareholder Circular and Schedules General Meeting on 28 September 2026 to Approve Fundraising Plans

Renalytix plc (RENX) Issues Shareholder Circular and Schedules General Meeting on 28 September 2026 to Approve Fundraising Plans →

Renalytix plc (LSE: RENX; OTCQB: RNLXY), a precision medicine diagnostics firm specializing in kidney disease, has announced the distribution of a shareholder circular and Notice of General Meeting set for 28 September 2026. This circular,…